Baeuerle Patrick
- SEC CIK
- 0001362054
No open-market purchases or sales filed in the past year.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.Chief Scientific Officeras of Feb 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Baeuerle Patrick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2021 (view filing) | Sep 8 | 1 day | Baeuerle PatrickSee Remarks | SSale | −11.0K | $28.45 | −$312.9K | −100.0%0 after | |
| Aug 26, 2021 (view filing) | Aug 10 | 16 daysLate | Baeuerle PatrickSee Remarks | SSale | −11.0K | $27.00 | −$297.0K | −100.0%0 after |